Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume

被引:0
作者
Yang Zhang
Rui Peng
Xiaojuan Li
Gaowa Cheng
Ximing Wang
Jinxing Yu
Muxing Hua
Xi Chen
Zhou Zhou
机构
[1] Fuwai Hospital,Diagnostic Laboratory Service, State Key Laboratory of Cardiovascular Disease
[2] National Center for Cardiovascular Diseases,Department of Laboratory Medicine
[3] Chinese Academy of Medical Sciences,undefined
[4] Peking Union Medical College,undefined
[5] Yunnan Fuwai Cardiovascular Hospital,undefined
来源
Thrombosis Journal | / 19卷
关键词
Dual antiplatelet therapy; Platelet function tests; High on-treatment platelet reactivity; Mean platelet volume;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 296 条
[1]  
Steinhubl SR(2002)Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial Jama. 288 2411-2420
[2]  
Berger PB(2001)Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494-502
[3]  
Mann JT(2003)Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation. 107 2908-2913
[4]  
Fry ET(2004)Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation J Am Coll Cardiol 44 20-24
[5]  
DeLago A(2010)Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 919-933
[6]  
Wilmer C(2009)Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation. 119 237-242
[7]  
Yusuf S(2009)Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation J Thromb Haemost 7 1556-1565
[8]  
Zhao F(2012)Safety profile and bleeding risk of ticagrelor compared with clopidogrel Expert Opin Drug Saf 11 959-967
[9]  
Mehta SR(2016)Pharmacodynamic effects of switching from Prasugrel to Ticagrelor: results of the prospective, randomized SWAP-3 study JACC Cardiovasc Interv 9 1089-1098
[10]  
Chrolavicius S(2016)2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and Management of Patient